Pdt Partners, LLC Rapt Therapeutics, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $519,564 - $686,778	-17,400 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $243,962 - $542,711	-13,561 Reduced 43.8%	17,400 $553,000
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $330,432 - $505,147	20,652 Added 200.33%	30,961 $687,000
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $163,810 - $421,328	10,309 New	10,309 $204,000

147

29.2M

709K

1.06M

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $82.7M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.